Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
Based on historical reporting patterns, Shattuck Labs typically reports earnings before market open, meaning Day 0 represents the first trading session where investors react to results, while Day +1 captures follow-through momentum.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-05-07 | -$0.42 (-6.29%) | $0.70 (10.48%) | +$0.59 (+9.42%) | $0.56 (8.95%) |
| 2026-03-05 | +$0.37 (+7.82%) | $0.64 (13.53%) | +$0.89 (+17.45%) | $0.82 (16.08%) |
| 2025-11-06 | -$0.08 (-3.92%) | $0.16 (7.84%) | +$0.02 (+1.02%) | $0.15 (7.65%) |
| 2025-08-14 | +$0.05 (+6.13%) | $0.09 (10.65%) | +$0.14 (+16.23%) | $0.20 (23.25%) |
| 2025-05-01 | +$0.09 (+9.20%) | $0.16 (16.44%) | -$0.08 (-7.81%) | $0.06 (5.95%) |
| 2025-03-27 | -$0.04 (-3.39%) | $0.11 (9.32%) | -$0.08 (-7.46%) | $0.13 (11.40%) |
| 2024-11-14 | +$0.15 (+12.30%) | $0.36 (29.51%) | -$0.14 (-9.85%) | $0.22 (16.06%) |
| 2024-08-01 | -$0.21 (-5.28%) | $0.31 (7.79%) | -$0.12 (-3.18%) | $0.23 (6.10%) |
| Avg Abs Move | 6.79% | 13.19% | 9.05% | 11.93% |
Shattuck Labs has demonstrated significant volatility around earnings releases, with an average absolute Day 0 move of 6.79% and Day +1 move of 9.05%. The most recent earnings on May 7, 2026, saw the stock decline 6.29% on Day 0 before rebounding with a 9.42% gain on Day +1, illustrating the stock's tendency for volatile two-day swings. The March 2026 report was particularly dramatic, with a 7.82% Day 0 gain followed by a 17.45% surge on Day +1, totaling a massive two-day rally.
The historical data shows considerable variability in both direction and magnitude, with Day 0 moves ranging from a 12.30% gain to a 5.28% decline, and Day +1 moves spanning from a 17.45% gain to a 9.85% decline. The average Day 0 range of 13.19% and Day +1 range of 11.93% underscore the stock's tendency for wide intraday swings during earnings periods. Investors should prepare for substantial volatility, particularly given the stock's recent strong performance and elevated positioning above all moving averages.
| Metric | Value |
|---|---|
| Expiration Date | 08/21/26 (DTE 9) |
| Expected Move | $0.38 (5.11%) |
| Expected Range | $7.11 to $7.87 |
| Implied Volatility | 138.87% |
The options market is pricing in an expected move of 5.11% for the upcoming earnings release, which is notably more conservative than the stock's historical average absolute Day 0 move of 6.79% and Day +1 move of 9.05%. This suggests options traders may be underpricing the potential volatility, creating possible opportunities for those expecting a larger-than-usual reaction based on STTK's historical earnings behavior.
Analyst sentiment toward Shattuck Labs is decidedly bullish, with the consensus rating at 4.73 out of 5.00, reflecting strong conviction in the stock's prospects. The current analyst breakdown shows 9 Strong Buys, 1 Moderate Buy, and 1 Hold, with no sell ratings among the 11 analysts covering the stock. This represents an improved sentiment trend, as the Strong Buy count increased from 7 to 9 over the past month while the overall rating ticked up from 4.67 to 4.73.
The average price target of $13.88 implies substantial upside of approximately 85% from the current price of $7.49, with individual targets ranging from a low of $10.00 to a high of $18.00. The wide range in price targets reflects differing views on the timeline and probability of success for STTK's clinical programs, but even the most conservative target suggests meaningful appreciation potential. The recent strengthening of analyst sentiment, combined with the stock's consistent earnings beats, indicates growing confidence in management's execution and the company's strategic direction heading into this earnings release.
Shattuck Labs enters earnings with strong technical momentum, as the stock is trading above all key moving averages. At $7.49, STTK is positioned above its 5-day MA ($7.25), 10-day MA ($7.31), 20-day MA ($7.19), 50-day MA ($6.28), 100-day MA ($6.48), and 200-day MA ($5.03), demonstrating broad-based strength across all timeframes. The stock has gained nearly 49% from its 200-day moving average, reflecting a powerful longer-term uptrend.
The Barchart Technical Opinion currently stands at 88% Buy, unchanged from both one week ago and one month ago, indicating sustained bullish momentum without signs of exhaustion. This stability in the signal suggests the rally has been orderly rather than parabolic.
Timeframe Analysis:
Trend Characteristics: The combination of "Good" strength and "Strongest" direction indicates STTK is in a robust uptrend with powerful directional momentum, creating a supportive technical environment for the earnings release.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $7.25 | 50-Day MA | $6.28 |
| 10-Day MA | $7.31 | 100-Day MA | $6.48 |
| 20-Day MA | $7.19 | 200-Day MA | $5.03 |
The technical setup is decidedly supportive heading into earnings, with the stock maintaining position above all moving averages and generating maximum buy signals in both short-term and long-term timeframes. The 50-day moving average at $6.28 represents the nearest significant support level, approximately 16% below current prices, while the rising 20-day MA at $7.19 provides more immediate support. However, the strong rally into earnings does create some risk of a "buy the rumor, sell the news" reaction if results fail to exceed elevated expectations, particularly given the stock's historical volatility around earnings releases. The technical picture suggests any pullback would likely find support at the rising moving averages, while a positive surprise could propel the stock toward the analyst price targets in the $10-$18 range.